AU2003235912A1 - Spiro-ring compound - Google Patents
Spiro-ring compoundInfo
- Publication number
- AU2003235912A1 AU2003235912A1 AU2003235912A AU2003235912A AU2003235912A1 AU 2003235912 A1 AU2003235912 A1 AU 2003235912A1 AU 2003235912 A AU2003235912 A AU 2003235912A AU 2003235912 A AU2003235912 A AU 2003235912A AU 2003235912 A1 AU2003235912 A1 AU 2003235912A1
- Authority
- AU
- Australia
- Prior art keywords
- spiro
- ring compound
- compound
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002-135988 | 2002-05-10 | ||
| JP2002135988 | 2002-05-10 | ||
| JP2002-214248 | 2002-07-23 | ||
| JP2002214248 | 2002-07-23 | ||
| PCT/JP2003/005812 WO2003095427A1 (en) | 2002-05-10 | 2003-05-09 | Spiro-ring compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003235912A1 true AU2003235912A1 (en) | 2003-11-11 |
Family
ID=29422399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003235912A Abandoned AU2003235912A1 (en) | 2002-05-10 | 2003-05-09 | Spiro-ring compound |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2003095427A1 (ja) |
| AU (1) | AU2003235912A1 (ja) |
| WO (1) | WO2003095427A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8232289B2 (en) | 2009-11-16 | 2012-07-31 | Eli Lilly And Company | Spiropiperidine compounds as ORL-1 receptor antagonists |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| JP2008510728A (ja) | 2004-08-19 | 2008-04-10 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体のモジュレーター |
| US7863449B2 (en) * | 2004-11-29 | 2011-01-04 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| EP1988892A2 (en) | 2006-02-22 | 2008-11-12 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| ATE517106T1 (de) | 2006-02-22 | 2011-08-15 | Vertex Pharma | Kondensierte spiropiperidine als modulatoren muskarinartiger rezeptoren |
| MX2012005690A (es) | 2009-11-16 | 2012-06-13 | Lilly Co Eli | Compuestos de espiropiperidina como antagonista del receptor orl-1. |
| WO2011140425A1 (en) | 2010-05-06 | 2011-11-10 | Vertex Pharmaceuticals Incorporated | Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
| SG189019A1 (en) * | 2010-10-18 | 2013-05-31 | Cerenis Therapeutics Holding Sa | Compounds, compositions and methods useful for cholesterol mobilisation |
| TW201604196A (zh) | 2011-02-02 | 2016-02-01 | 維泰克斯製藥公司 | 作為離子通道調節劑之吡咯并吡-螺環哌啶醯胺 |
| US10385070B2 (en) | 2011-02-18 | 2019-08-20 | Vertex Pharmaceuticals Incorporated | Chroman-spirocyclic piperidine amides as modulators of ion channels |
| EP2686325B1 (en) | 2011-03-14 | 2016-12-14 | Vertex Pharmaceuticals Incorporated | Morpholine-spirocyclic piperidine amides as modulators of ion channels |
| EP4455145A3 (en) * | 2015-12-02 | 2025-03-12 | Astraea Therapeutics, LLC | Piperidinyl nociceptin receptor compounds |
| US10112924B2 (en) | 2015-12-02 | 2018-10-30 | Astraea Therapeutics, Inc. | Piperdinyl nociceptin receptor compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55143980A (en) * | 1979-04-27 | 1980-11-10 | Dai Ichi Seiyaku Co Ltd | Anti-allergic preparation |
| IL96507A0 (en) * | 1989-12-08 | 1991-08-16 | Merck & Co Inc | Nitrogen-containing spirocycles and pharmaceutical compositions containing them |
| AU1682400A (en) * | 1998-12-09 | 2000-06-26 | Banyu Pharmaceutical Co., Ltd. | 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds |
-
2003
- 2003-05-09 AU AU2003235912A patent/AU2003235912A1/en not_active Abandoned
- 2003-05-09 JP JP2004508514A patent/JPWO2003095427A1/ja not_active Withdrawn
- 2003-05-09 WO PCT/JP2003/005812 patent/WO2003095427A1/ja not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8232289B2 (en) | 2009-11-16 | 2012-07-31 | Eli Lilly And Company | Spiropiperidine compounds as ORL-1 receptor antagonists |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003095427A1 (en) | 2003-11-20 |
| JPWO2003095427A1 (ja) | 2005-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003266949A1 (en) | Compounds | |
| AU2003224111A1 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
| AU2003221098A1 (en) | Oligofluorenylene compounds | |
| WO2003072535A8 (en) | Substituted hydroxyethylamines | |
| AU2003279366A1 (en) | Novel compounds | |
| AU2003238043A1 (en) | Substituted imidazotriazines | |
| AU2003245984A1 (en) | Hetero-cyclicaly substituted imidazotriazines | |
| AU2003220963A1 (en) | Chromene compound | |
| AU2003235912A1 (en) | Spiro-ring compound | |
| AU2003294900A1 (en) | Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides | |
| AU2003212366A1 (en) | Substituted 4-aminocyclohexanols | |
| AU2003216859A1 (en) | Amidoacetonitrile compounds | |
| AU2002953066A0 (en) | Reel | |
| AUPS044102A0 (en) | New compound | |
| AU2002951868A0 (en) | Compound i | |
| AU2003255834A1 (en) | Luminescent compounds | |
| AU2003292667A1 (en) | Benzocycloheptapyridine compounds | |
| AU2003251259A1 (en) | Novel compounds | |
| AU2003275480A1 (en) | Compounds | |
| AU2003255322A1 (en) | Compounds | |
| AU2003242474A1 (en) | Novel promoter | |
| AU2003302705A1 (en) | Germ-responsive promoter | |
| AU2003903629A0 (en) | New compound | |
| AU2003903205A0 (en) | New compound | |
| AU2002344387A1 (en) | Multifunction-pillow |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
| TH | Corrigenda |
Free format text: IN VOL 18, NO 2, PAGE(S) 590 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME TAISHO PHARMACEUTICAL CO., LTD., APPLICATION NO. 2003235912, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003 |